FXAIX
Price
$265.83
Change
-$2.30 (-0.86%)
Updated
Aug 20 closing price
Net Assets
833.14B
GILIX
Price
$25.97
Change
+$0.09 (+0.35%)
Updated
Aug 21 closing price
Net Assets
282.57M
Interact to see
Advertisement

FXAIX vs GILIX

FXAIX vs GILIX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. GILIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a StrongBuy and GILIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 833B vs. GILIX (283M). FXAIX pays higher dividends than GILIX: FXAIX (1.06) vs GILIX (0.36). FXAIX was incepted earlier than GILIX: FXAIX (15 years) vs GILIX (14 years). GILIX (1.00) is less costly to investors than FXAIX (0.01). GILIX is a more actively managed with annual turnover of: 141.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than GILIX: FXAIX (0) vs GILIX (2000000). FXAIX (21.35) and GILIX (20.32) have marching annual gain over last year. FXAIX return over 5 years is better than : 84.67 vs. GILIX (0.35).
FXAIXGILIXFXAIX / GILIX
Total Expense Ratio0.011.002%
Annual Report Gross Expense Ratio0.011.002%
Fund Existence15 years14 years-
Gain YTD12.43714.05488%
Front LoadN/AN/A-
Min. Initial Investment02000000-
Min. Initial Investment IRAN/AN/A-
Net Assets833B283M294,346%
Annual Yield % from dividends1.060.36293%
Returns for 1 year21.3520.32105%
Returns for 3 years81.1548.61167%
Returns for 5 years84.670.3523,945%
Returns for 10 years286.5736.65782%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX55.570.84
+1.53%
Rydex Biotechnology C
RSLBX70.040.57
+0.82%
American Funds SMALLCAP World R-2
RYPNX20.180.16
+0.80%
Royce Small-Cap Opportunity Invmt
VSORX54.480.35
+0.65%
Victory Sycamore Small Company Opp R6
BLNIX15.060.05
+0.33%
Meeder Balanced Institutional